Evofem Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Evofem Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • Evofem Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.37M, a 104% decline year-over-year.
  • Evofem Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.94M, a 117% decline year-over-year.
  • Evofem Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $53M.
  • Evofem Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$76.7M, a 62.6% increase from 2021.
  • Evofem Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$205M, a 44.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.94M -$2.37M -$68.4M -104% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $60.4M $1.35M +$9.91M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 $50.5M -$4.81M -$2.46M -104% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 $53M -$2.11M +$6.22M +74.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $46.8M $66M -$23.5M -26.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $70.3M -$8.56M +$117M +93.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$47.2M -$2.35M +$29.5M +92.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$76.7M -$8.34M +$43.2M +83.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$120M $89.5M +$164M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$283M -$126M -$92.6M -277% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$191M -$31.9M +$14.3M +30.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$205M -$51.6M -$11M -27% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-27
Q3 2021 -$194M -$74.1M -$44.2M -148% Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-06
Q2 2021 -$150M -$33.4M +$19.2M +36.5% Apr 1, 2021 Jun 30, 2021 10-Q 2023-01-06
Q1 2021 -$169M -$46.2M -$27M -141% Jan 1, 2021 Mar 31, 2021 10-Q 2023-01-06
Q4 2020 -$142M -$40.6M -$27.9M -219% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$114M -$29.9M -$16.1M -117% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$98.3M -$52.7M -$17.2M -48.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$81.1M -$19.1M -$1.08M -5.97% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$80M -$12.7M +$2.26M +15.1% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$82.3M -$13.8M +$4.63M +25.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$86.9M -$35.5M -$12.2M -52.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$74.7M -$18.1M +$51M +73.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$126M -$15M +$4.51M +23.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$130M -$18.4M +$55.6M +75.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$186M -$23.2M -$16.7M -257% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$169M -$69.1M -$63.8M -1211% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$105M -$19.5M -$5.26M -36.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$100M -$74M -$40.6M -121% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$59.5M -$6.51M +$348K +5.07% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$59.8M -$5.27M +$7.97M +60.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$67.8M -$14.2M -$4.72M -49.6% Oct 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
Q3 2016 -$63.1M -$33.5M -$16.2M -93.9% Jul 1, 2016 Sep 30, 2016 8-K/A 2018-04-06
Q2 2016 -$46.9M -$6.86M +$2.62M +27.6% Apr 1, 2016 Jun 30, 2016 8-K/A 2018-04-06
Q1 2016 -$49.5M -$13.2M -$6.34M -91.9% Jan 1, 2016 Mar 31, 2016 8-K/A 2018-04-06
Q4 2015 -$43.2M -$9.52M -$6.62M -228% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$36.5M -$17.3M -$13.2M -327% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$23.3M -$9.48M -$7.2M -316% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$16.1M -$6.9M -$5.3M -331% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$10.8M -$2.9M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 -$4.04M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.28M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.6M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.